Evidence map›Paper›PMID 40603843›Full record

ArticleNature communications2025

Glucosamine activates intestinal P-glycoprotein inhibiting drug absorption.

Qinghua Wu, Qing Wang, Xiaohong Luo, Peng Jin, Ming Jin, Sajid Hussain, Yiming Qi, Junfeng Mo, Yinglan Yu, Hao Shao and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qinghua WuCollege of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.ORCID http://orcid.org/0000-0002-1130-470X
Qing WangChildren's Hospital of Chongqing Medical University, Chongqing, 400014, China.ORCID http://orcid.org/0009-0003-3408-8709
Xiaohong LuoDepartment of Clinical Laboratory, The Fourth People's Hospital of Liaocheng, Shandong, 252000, China.
Peng JinCollege of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
Ming JinCollege of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
Sajid HussainCollege of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
Yiming QiCollege of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
Junfeng MoCollege of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
Yinglan YuCollege of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
Hao ShaoCollege of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
Lei LuoCollege of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China. drluolei@swu.edu.cn.ORCID http://orcid.org/0000-0002-7060-434X

Funding

Chongqing Science and Technology Commission (Chongqing Science and Technology Commission, Chongqing People's Municipal Government) CSTB2023NSCQ-JQX0002
6 · The paper itself

Abstract

P-glycoprotein (P-gp) is a crucial drug efflux transporter in the gastrointestinal tract, reducing drug uptake and expelling harmful xenobiotics to prevent pathological changes. Current P-gp enhancers primarily increase P-gp expression, requiring 1-3 days, thus missing the critical rescue window for acute poisoning. This study identifies glucosamine (GlcN) as a potent P-gp activator that swiftly enhances drug efflux, significantly reducing drug absorption without altering P-gp expression levels. GlcN directly binds to P-gp, boosting its transport efficiency. Only GlcN with a polymerization degree below 5 can activate P-gp, whereas higher polymerized chitooligosaccharides enhance drug absorption. Additionally, GlcN activation of P-gp has significant implications for cellular metabolism by expelling xenobiotics and metabolic by-products, maintaining cellular homeostasis. Our findings suggest GlcN's potential as an effective antidote for paraquat poisoning and offer a detoxification strategy. This research provides a foundational understanding for developing improved detoxification agents and metabolic modulators.

Indexed as

ATP Binding Cassette Transporter, Subfamily B, Member 1GlucosamineIntestinal AbsorptionAnimalsATP Binding Cassette Transporter, Subfamily BBiological TransportCaco-2 CellsHumansIntestinal MucosaMaleMiceParaquatATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily B, Member 1GlucosamineParaquat

Identifiers

PMID40603843
PMCPMC12222954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.